Navigation Links
Nestle Introduces PEPTAMEN® BARIATRIC Formula for the Critically-Ill Obese Patient
Date:2/1/2011

y targets.  

"The lack of consistent and appropriate nutrition interventions for the obese, critically-ill patient means that some patients may be overfed, others may be underfed and become malnourished, and others may not have their nutritional needs assessed at all. All of these scenarios can present problems with health outcomes and recovery rates," said Stephen McClave, M.D., Professor of Medicine, University of Louisville.

Obesity is a serious health concern because of its related complications and co-morbidities, including cardiovascular disease, metabolic disorders such as diabetes and respiratory disease. The increased rate of infections and complications associated with obesity in the ICU can be significant, costly and affect treatment across all settings.

"There is a known benefit with early nutritional intervention in the ICU patient. However, despite having more than 236 formulas, until recently, not one met the recommended amount of protein and calories suggested to help support improved patient outcomes for this patient population," said Robert Martindale, M.D., Ph.D., Chief of General Surgery, Oregon Health & Science University.

To address this important need, Nestle HealthCare Nutrition has developed a tube feeding formula, PEPTAMEN® BARIATRIC, with a unique protein-to-calorie ratio specifically designed to help meet the protein requirements of the critically-ill obese patient recommended in the 2009 Critical Care Nutrition Guidelines.(ii)

PEPTAMEN® BARIATRIC tube feeding formula is the latest addition to the Nestle PEPTAMEN® family of products. PEPTAMEN® is the only family of peptide formulas with over 50 clinical studies and more than 23 years of clinical experience. For the tube feeding of the critically-ill obese patient, PEPTAMEN® BARIATRIC formula provides 37 percent of calories from 100 percent whey protein, enzymatically hydrolyzed to produce peptides. The lipid blend in
'/>"/>

SOURCE Nestle HealthCare Nutrition, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety
2. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
3. Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial
4. Stater Bros. Introduces Free Personal Vitamin Recommendation Program
5. Ascension Orthopedics Introduces True Modularity With MOVEMENT™ Great Toe System
6. Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu
7. Hygeia Introduces Environmentally Preferable Product Breastpump Program to Enable Mothers to Recycle and Refurbish Used Breastpumps
8. Puritan Medical Products Introduces New Patent Pending Flocked Swab Technology
9. Zimmer Introduces a Move Forward in Mobile Bearing Knee Design
10. CentraState Healthcare System Selects MobileMD for Health Information Exchange; Introduces EMR Light to Healthcare Community
11. Advanced Radiology Introduces Baltimores First 1.2T High Field Open MRI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, Inc. ... medical device company focused on oncology with an ... liver cancers, announces the reporting of data from ... Hydrochloride for Injection with the Delcath Hepatic Delivery ... presentation at the Society of Surgical Oncology (SSO) ...
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... focus on Omega-3 therapies for cardiovascular disease and overall ... 763,752 common shares of the Corporation (the "Common Shares"). ... period of December 5 th , 2014 to March ... that is due on or before April 1, 2015. ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... , MOUNTAIN VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, ... submitted its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... is an inhalation product candidate being developed for the rapid ... The IND for Staccato loxapine was filed ...
... , DENVER, Dec. 14 Corgenix Medical Corporation (OTC ... diagnostic test kits, and BG Medicine, Inc. (BGM), a ... agreement whereby Corgenix will manufacture BGM Galectin-3 diagnostic products ... BG Medicine. BG Medicine is seeking regulatory clearance in ...
Cached Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2
(Date:3/27/2015)... March 27, 2015 Ticket Down is a ... CenturyLink Center in Omaha, Nebraska on Friday, May 8th ... more concert dates will be added in Omaha as Garth ... demand. , The Garth Brooks World Tour is continuing its ... announcement that Garth Brooks and Trisha Yearwood will bring their ...
(Date:3/27/2015)... March 27, 2015 DrugDev announced company ... Easy was named to the 2015 Philadelphia Business Journal ... list spotlights 40 dynamic, up-and-coming leaders less than 40 ... involvement. Winners are honored at an awards program in ... Philadelphia Business Journal. , Lyn Kremer, Publisher of the ...
(Date:3/27/2015)... Endure Yoga is launching WOD (Workout ... This new program matches yoga poses with functional fitness ... down. This program utilizes yoga to improve recovery, prevent ... , Karen Lefurgy, competitive athlete at CrossFit ... I started Crossfit® training, but quickly, due to time ...
(Date:3/27/2015)... According to Health Day , on March ... Syndrome (NAS) are causing alarm for Florida officials. Infants ... for a month of their lives- and can experience ... The condition is precipitated by drug use during pregnancy. ... employing medically assisted drug treatment) will also inflict NAS ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 SMI (Silicon ... announced it has launched the SM1120 MEMS based ultra-miniature ... The microsensor profile at only 220um x 75um ... to reach challenging locations. With industry leading in ... the SM1120 provides a broad operating pressure range from ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2
... on the Judiciary Committee staff of Senator Tom Coburn, Mary ... as Of Counsel to assist in spearheading America,s ... confirmation of U.S. Supreme Court nominee Judge Sotomayor. , ... am very pleased to have Mary join our team. ...
... with poor prognosis. This warrants the development of ... have demonstrated poor efficacy of adenoviral gene therapy ... on pancreatic cancer cells such as the coxsackie ... seems a promising option to improve adenoviral entry ...
... 2009 While Ontario women live longer than men, ... and chronic conditions, according to a new women,s health ... What,s more, low-income women have more chronic conditions, greater ... high-income groups. While inequities in health among men ...
... donations exceed expectations , , BIRMINGHAM, England, June ... world of a crippling and potentially fatal disease, Rotary ... toward its US$200 Million Challenge, a fundraising effort to ... Chair Jonathan Majiyagbe announced the new figure to an ...
... ... New Depreciation Wizard Feature for its Asset Tracking Application, Passport Assets, Enabling its Customers to ... , ... 23, 2009 -- ASAP Systems today announced the release of a depreciation wizard ...
... , Incentive Programs Driving Activities and Behavior Changes to Reduce ... ( http://www.incentone.com ), the leading provider ... health care industry, announced today that ... millionth health milestone. The 2 million milestones driven by IncentOne,s ...
Cached Medicine News:Health News:Mary Harned Joins Americans United for Life, Set to Oppose Sotomayor Confirmation 2Health News:Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells 2Health News:Ontario women live longer but don't prosper: Study 2Health News:Ontario women live longer but don't prosper: Study 3Health News:Ontario women live longer but don't prosper: Study 4Health News:Rotary Marks Progress in Drive to Eradicate Polio 2Health News:Rotary Marks Progress in Drive to Eradicate Polio 3Health News:ASAP Systems Launches New Depreciation Feature Enabling its Customers to Develop Custom Formulas to Calculate Depreciation Of Their Fixed Assets Inventory 2Health News:IncentOne Achieves 2 Millionth Health Milestone 2
This design features a solid red iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Medicine Products: